Turning Point Benefit Group »

Vertex Pharmaceuticals Incorporated shares owned by Turning Point Benefit Group

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Turning Point Benefit Group from 13F filings

Historical chart of Turning Point Benefit Group investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Turning Point Benefit Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Turning Point Benefit Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $11k 24 453.33
2025-09-30 $404 1 404.00

More positions owned by Turning Point Benefit Group

Spdr Series Trust Etf (BIL)
Ishares Tr Etf (FLOT)
Spdr Series Trust Etf (SPYM)
Northern Lts Fd Tr Iv Etf (WWJD)
Capital Group U S Multi Sec Etf (CGMS)
Wheaton Precious Metals Corp (WPM)
Dimensional Etf Trust Etf (DFIV)
Vanguard Whitehall Fds Etf (VYMI)
Bluerock Pvt Real Estate (BPRE)
T Rowe Price Etf Etf (TFLR)
Spdr Index Shs Fds Etf (SPEM)
Timothy Plan cmn (TPSC)
Invesco Exch Traded Fd Tr Ii Etf (QQQM)
First Tr Exchange-traded Etf (FDL)
Capital Group Divid Value Etf Shs Creation Unit (CGDV)

View all positions for Turning Point Benefit Group

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated